Quality & Regulatory

Established in 2019, as a joint venture by 

Established in 2019, as a joint venture by Genovior Biotech Corporation and New Hope Group(a Fortune 500 company), Fujian Genohope Biotech Ltd. is a leading comprehensive Contract Injectable Drug Manufacturing Organization in China. The company is committed to create an affordable high value medicine environment worldly. Genohope mainly specialize on high valuable Diabetes& Obesity and Oncology products. Not only High Potency Active Pharmaceutical Ingredients(HP APIs) but also various Injectable Finished Dosage Forms(FDF） can be customized,developed and manufactured.

With over 220 talents and 20-year-experience core Research and Development among them, Genohope has an outstanding privilege of efficient and effective output. So far, the business has achieved a dozen of product portfolio and some of them have been commercialized. The product portfolio includes many more high potency medicines Liraglutide, Semaglutide, Fulvestrant, Carfilzomib, Ranibizumab and Ponatinib than Azacitidine, Bortezomib, Bumetanide, Landiolol , Telipressin, Leuprolide Mesylate and Peme